This hottest twist during the Lykos Therapeutics saga threatens An important overhaul of the corporation’s strategy and course, with Musk ally and billionaire investor Antonio Gracias appearing to want to choose the corporate back toward its nonprofit drug enhancement roots and a far more Doblinite philosophy.“There’s gonna be a lot of applic